Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein
KEYWORDS: people, vte, prophylaxis, risk, vte prophylaxis, surgery, lmwh, use, risk vte, pharmacological, consider, bleeding, undergoing, people undergoing, person

day and night until they no longer have significantly reduced mobility. [2010] 1.3.7 Remove anti-embolism stockings daily for hygiene purposes and to inspect skin condition. In people with a significant reduction in mobility, poor skin integrity or any sensory loss, inspect the skin 2 or 3 times a day, particularly over the heels and bony prominences. [2010] 1.3.8 Monitor the use of anti-embolism stockings and offer assistance if they are not being worn correctly. [2010] 1.3.9 Stop the use of anti-embolism stockings if there is marking, blistering or discolouration of the skin, particularly over the heels and bony prominences, or if the person experiences pain or discomfort. If suitable, offer intermittent pneumatic compression as an alternative. [2010, amended 2018] 1.3.10 Do not offer intermittent pneumatic compression to people with a known allergy to the material of manufacture. [2010, amended 2018] 1.3.11 Advise the person to wear their device for as much time as possible. [2010, amended 2018] Pharmacological prophylaxis 1.3.12 For pharmacological VTE prophylaxis in people under 18, follow the recommendations on apixaban, aspirin, dabigatran etexilate, fondaparinux sodium, low-molecular-weight heparin (LMWH) and rivaroxaban in this guideline. [2018] In March 2018, the use of these drugs in young people under 18
